Perlmutter Cancer Center — New York, New York

Perlmutter Cancer Center is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Perlmutter Cancer Center has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: Breast Neoplasms, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation.

Sponsors: Pfizer, AstraZeneca, Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Perlmutter Cancer Center?

Perlmutter Cancer Center has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Perlmutter Cancer Center conducted?

Perlmutter Cancer Center has 5 clinical trials on record, with 2 currently active. Their work covers Breast Neoplasms, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation.

Is Perlmutter Cancer Center accredited by Crixeo Health?

Yes — Perlmutter Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Perlmutter Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.